HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Thymic epithelial neoplasms: updates on diagnosis, staging, biology and management in France].

Abstract
Thymic epithelial neoplasms are rare malignancies with about 250 new incident cases in France every year. The WHO histologic classification distinguishes thymoma and thymic carcinoma which are tumors with different biological and clinical behaviors and outcomes. The Masaoka-Koga staging system is considered as a reference and is also of prognosis value. Diagnosis, multimodal treatment and follow-up of thymic epithelial neoplasms require a multidisciplinary approach where surgery is the cornerstone treatment. A national expert center coordinates thymic epithelial neoplasms management with 12 other regional expert centers through the French organization named RYTHMIC (www.rythmic.org). Patient's files have to be discussed at regional or national multidisciplinary staff. A group of expert pathologists will centrally review tumors when the diagnosis or classification is a matter of controversy. Among its objectives, RYHTMIC has to promote medical education, patient's information and research. This review focuses on RYTHMIC guidelines and data regarding multimodal management and targeted therapies in epithelial thymic neoplasms.
AuthorsJulien Hadoux, Nicolas Girard, Benjamin Besse
JournalBulletin du cancer (Bull Cancer) Vol. 99 Issue 11 Pg. 1045-55 (Nov 2012) ISSN: 1769-6917 [Electronic] France
Vernacular TitleTumeurs épithéliales thymiques : actualités dans la prise en charge en France.
PMID23131309 (Publication Type: Journal Article, Review)
Chemical References
  • ErbB Receptors
  • Proto-Oncogene Proteins c-kit
Topics
  • ErbB Receptors (metabolism)
  • France
  • Genes, erbB-1
  • Humans
  • Molecular Targeted Therapy (methods)
  • Myasthenia Gravis (etiology)
  • Neoplasm Staging (methods)
  • Neoplasms, Glandular and Epithelial (diagnosis, metabolism, pathology, therapy)
  • Neovascularization, Pathologic (therapy)
  • Paraneoplastic Syndromes (etiology)
  • Practice Guidelines as Topic
  • Prognosis
  • Proto-Oncogene Proteins c-kit (metabolism)
  • Rare Diseases (diagnosis, metabolism, pathology, therapy)
  • Thymoma (diagnosis, metabolism, pathology, therapy)
  • Thymus Neoplasms (diagnosis, metabolism, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: